HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hepatorenal Syndrome

Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.
Also Known As:
Syndrome, Hepatorenal
Networked: 624 relevant articles (66 outcomes, 64 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Fibrosis (Cirrhosis)
2. Alcoholic Hepatitis
3. Ascites
4. Liver Diseases (Liver Disease)
5. End Stage Liver Disease

Experts

1. Ginès, Pere: 22 articles (11/2015 - 03/2002)
2. Arroyo, Vicente: 16 articles (11/2015 - 03/2002)
3. Wong, Florence: 10 articles (12/2015 - 03/2003)
4. Cárdenas, Andrés: 8 articles (06/2013 - 03/2002)
5. Guevara, Mónica: 7 articles (05/2014 - 10/2002)
6. Krag, Aleksander: 7 articles (10/2012 - 12/2007)
7. Solà, Elsa: 6 articles (11/2015 - 08/2012)
8. Møller, Søren: 6 articles (10/2012 - 05/2005)
9. Bendtsen, Flemming: 6 articles (10/2012 - 05/2005)
10. Jiménez, Wladimiro: 6 articles (08/2012 - 03/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hepatorenal Syndrome:
1. terlipressinIBA
2. Vasoconstrictor AgentsIBA
3. Vasopressins (Vasopressin)IBA
4. Pentoxifylline (Trental)FDA LinkGeneric
5. Midodrine (Midon)FDA LinkGeneric
6. OrnipressinIBA
7. Octreotide (Sandostatin)FDA LinkGeneric
8. CreatinineIBA
9. Norepinephrine (Noradrenaline)FDA LinkGeneric
10. Acetylcysteine (Siran)FDA LinkGeneric

Therapies and Procedures

1. Liver Transplantation
2. Transplants (Transplant)
3. Transplantation (Transplant Recipients)
4. Surgical Portasystemic Shunt (Portosystemic Shunt)
5. Kidney Transplantation